Reports Q1 revenue $18.6M, consensus $17.49M. “Q1 2025 was another exceptional quarter for Paysign (PAYS), as we achieved record revenue, operating income and Adjusted EBITDA,” said Mark Newcomer, President and CEO of Paysign. “We delivered 41.0% year-over-year revenue growth and a 193.3% increase in Adjusted EBITDA, along with a 10.3 percentage point expansion in gross margins. Our patient affordability business once again outperformed expectations, delivering an impressive 260.8% revenue increase compared to the first quarter of 2024. We ended the quarter with 90 active patient affordability programs, adding 14 net patient affordability programs during the quarter. Our pipeline remains robust, and we are extremely confident that the business will continue its current growth trajectory.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PAYS:
- PaySign Inc’s Earnings Call Highlights Growth Amid Challenges
- PaySign’s Strong Financial Performance and Growth Prospects Justify Buy Rating with Over 200% Potential Return
- PaySign’s Strong Financial Performance and Growth Prospects Justify Buy Rating
- Paysign price target lowered to $5 from $7 at Barrington
- Paysign, Inc. Reports Strong 2024 Financial Growth